EXM is a unique, minimally manipulated, tissue matrix allograft processed from human placental tissues. This tissue matrix contains collagens, growth factors, a native population of cells, along with other key biologic components.

No. Our provider does not use embryonic tissue. Their products come from ethically sourced, donated perinatal tissue, such as umbilical cord tissue, following full-term, healthy births with donor consent.

Safety is a top priority. Our provider follows all FDA regulations regarding tissue processing. It begins with meticulous screening of the donor mother and father, as well as family members across multiple generations, to identify qualified candidates. There is 100% chain of custody. A recovery specialist will collect the postnatal donation at the designated hospital and immediately return to the lab with the donation. Once processed all materials are quarantined for 14 days and thoroughly tested for bacterial and disease contamination by a CLIA-certified lab, ensuring a clean and safe product.

Yes. All products from our provider comply with U.S. FDA regulations for human cells, tissues, and cellular and tissue-based products (HCT/Ps) under 21 CFR Part 1271. Section 361 of the Public Health Service Act, along with Title 21, Code of Federal Regulations (CFR) Part 1271, governs the regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps) that are minimally manipulated, intended for homologous use, and do not pose significant risk to public health. Thus they do not require an IND or premarket approval to be commercially sold.

Outside of the country labs are generally using expanded or multiplied cells. It's a cost saving measure but, expanded cells lose their regenerative capacity each generation they are expanded.

Our cells are master cells that come within the original material and maintain 100% of their regenerative capacity, maintaining a higher potency.

No. The products that are being used are derived from perinatal tissue. Perinatal tissue has unique immunogenic suppressant properties. They are also all processed in sterile environments to ensure that there is no contamination. Perinatal tissue is also a universally accepted product.

EXM is designed with unique properties that may help support the body's natural processes. Through a chemotactic response, the material is intended to interact with the body and may assist in promoting cellular activity in areas of concern. At the cellular level, this material is designed to support cell rejuvenation and may contribute to the renewal of cells.

No. Our ECM therapies are not classified as performance-enhancing drugs.

Individual experiences vary. Some patients report feeling changes within weeks, while others may take longer.

Platelet-Rich Plasma (PRP) uses the patient's own blood components. Our products are derived from perinatal tissue, potentially offering a different range of growth factors and cytokines. In general, you need more PRP treatments to see the same results as a single treatment of our ECM product.

We like to be transparent about our pricing and you can find pricing for all of our treatments by clicking in to the treatment page. The cost of ECM can vary based on the specific application and the level of care needed. However, many patients find it to be a truly valuable investment in their long-term health, vitality, and quality of life.

This depends on individual factors and desired outcomes. We will outline a plan tailored to your needs.

ECM is a minimally invasive treatment. Most patients report only mild discomfort during and after the procedure.

Choose from one of our treatment packages or schedule a customized consultation with us and we can discuss your specific concerns and go over a detailed treatment plan.